제품 확장 모델

Neofuser Onco

With Michrochannel Technology specially for 5-fluorouracil in Oncology

Neofuser Onco is designed for the infusion of 5-Fluorouracil, Trabectedin, and other oncology drugs, ensuring precise delivery.
It incorporates a microfluidic chip technology with a flow limiter specifically developed for 5-fluorouracil infusion, enhancing control.

The wide-channel flow regulator, tailored for 5-Fluorouracil infusions, maintains high flow accuracy crucial for effective treatment.
Its wide channels enable smooth, uninterrupted flow, eliminating delays caused by fine crystal precipitations of 5-Fluorouracil.
UV protection is integrated to safeguard the medication's potency and stability throughout the infusion process.
The cross-sectional area of the microfluidic channel in the L50-O is about 4.6 times larger than the L50 50um capillary, preventing blockages caused by drug crystallization.
The length of the normal capillary is 15 mm, and the length of the microchannel is 420 mm.
The flow rate increases as the cross-sectional area of the tube becomes larger and the length becomes shorter. To adjust the flow rate, the cross-sectional area is increased by approximately 4.6 times, while the length is extended by about 23 times.

The Neofuser Onco model is specifically designed for chemotherapy drug infusion. To minimize blockages caused by the high crystallization tendency of certain anticancer agents, it features a microchannel with a cross-sectional area 4.6 times larger than conventional models.

▣ Volume(ml) : 60ml(S), 100ml(M), 180ml(R), 275ml(L), 450ml(X)
▣ Fixed flow rate(ml/hr) : 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 10ml/hr